MIT engineers repurpose wasp venom as an antibiotic drug
Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.
Department
Biological Engineering
Measuring cancer cell “fitness” reveals drug susceptibility
Together, cell growth rate and gene expression shed light on why some tumor cells survive treatment.
Potential arthritis treatment prevents cartilage breakdown
Injectable material made of nanoscale particles can deliver arthritis drugs throughout cartilage.
Sixteen grad students named to the Siebel Scholars class of 2019
MIT students from the fields of bioengineering, business, computer science, and energy science receive the prestigious awards.
Exploring unknowns in cancer, the human brain, and the road ahead
Double major Kerrie Greene builds connections in her research and her community.
Bridge to the future of engineering
The School of Engineering’s faculty leadership weigh in on what the MIT Stephen A. Schwarzman College of Computing will mean for their students and faculty.
Squeezing cells to cure diseases
Startup SQZ Biotech aims to open a new path in immunotherapy with its cell-compressing technique.
New CRISPR tool opens up more of the genome for editing
Enzyme can target almost half of the genome’s “ZIP codes” and could enable editing of many more disease-specific mutations.
Helping blood cells regenerate after radiation therapy
Method boosts differentiation of stem cells into mature blood cell types, may help leukemia and lymphoma patients.
Studying the hotbed of horizontal gene transfers
Global Microbiome Conservancy research reveals surprising new insights into human gut microbiomes.
Monitoring electromagnetic signals in the brain with MRI
Technique could be used to detect light or electrical fields in living tissue.
School of Engineering third quarter 2018 awards
Faculty members recognized for excellence via a diverse array of honors, grants, and prizes over the last quarter.
This RNA-based technique could make gene therapy more effective
Biological engineers design RNA circuits that enable precise control over the dose of therapeutic protein a patient receives.
Computer model offers more control over protein design
New approach generates a wider variety of protein sequences optimized to bind to drug targets.
Progress against pancreatic cancer
Lustgarten Foundation names MIT laboratory to improve understanding and treatment of a deadly disease